Comparative analysis of outcome in patients with hepatocellular carcinoma exceeding the milan criteria treated with liver transplantation versus partial hepatectomy

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 34, Issue 5, 2011, Pages 466-471

  Canter, Robert J ^a   Patel, Siddharth A ^b   Kennedy, Timothy ^a   Dangelica, Michael I ^a   Jarnagin, William R ^a   Fong, Yuman ^a   Blumgart, Leslie H ^a   Freeman, Richard B ^c   Dematteo, Ronald P ^a   Abt, Peter L ^d  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c TUFTS MEDICAL CENTER   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

expanded criteria; hepatocellular carcinoma; liver transplantation; partial hepatectomy

Indexed keywords

ARTICLE; CANCER MORTALITY; CANCER REGISTRY; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CAUSE OF DEATH; CRITERION VARIABLE; FEMALE; FOLLOW UP; HEPATITIS C VIRUS; HUMAN; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MILAN CRITERION; MODEL FOR END STAGE LIVER DISEASE SCORE; OVERALL SURVIVAL; PARTIAL HEPATECTOMY; PATIENT SELECTION; RISK FACTOR; SCORING SYSTEM; TREATMENT OUTCOME; UNIVERSITY OF CALIFORNIA AT SAN FRANCISCO CRITERION;

CARCINOMA, HEPATOCELLULAR; END STAGE LIVER DISEASE; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 80053360997     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e3181ec63dd     Document Type: Article

References (30)

1. Cha CH, Ruo L, Fong Y, et al. Resection of hepatocellular carcinoma in patients otherwise eligible for transplantation. Ann Surg. 2003;238:315- 321;discussion 321-323.
2. Llovet JM, Schwartz M, Mazzaferro V. Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis. 2005;25:181-200. (Pubitemid 40781071)
3. Margarit C, Escartin A, Castells L, et al. Resection for hepatocellular carcinoma is a good option in Child-Turcotte-Pugh class A patients with cirrhosis who are eligible for liver transplantation. Liver Transpl. 2005;11:1242-1251. (Pubitemid 41511939)
4. Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology. 1999;30:1434-1440.
5. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334:693-699. (Pubitemid 26079803)
6. Bigourdan JM, Jaeck D, Meyer N, et al. Small hepatocellular carcinoma in child A cirrhotic patients: hepatic resection versus transplantation. Liver Transpl. 2003;9:513-520. (Pubitemid 36621722)
7. Jonas S, Bechstein WO, Steinmuller T, et al. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology. 2001;33:1080-1086. (Pubitemid 32378206)
8. Hemming AW, Cattral MS, Reed AI, et al. Liver transplantation for hepatocellular carcinoma. Ann Surg. 2001;233:652-659. (Pubitemid 32378649)
9. Klintmalm GB. Liver transplantation for hepatocellular carcinoma: a registry report of the impact of tumor characteristics on outcome. Ann Surg. 1998;228:479-490. (Pubitemid 30194392)
10. Yoo HY, Patt CH, Geschwind JF, et al. The outcome of liver transplantation in patients with hepatocellular carcinoma in the United States between 1988 and 2001:5-year survival has improved significantly with time. J Clin Oncol. 2003;21: 4329-4335. (Pubitemid 46621808)
11. Yao FY, Ferrell L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology. 2001;33: 1394-1403. (Pubitemid 32496976)
12. Onaca N, Davis GL, Goldstein RM, et al. Expanded criteria for liver transplantation in patients with hepatocellular carcinoma: a report from the International Registry of Hepatic Tumors in Liver Transplantation. Liver Transpl. 2007;13:391-399. (Pubitemid 46444468)
13. Goodman J, Glasgow SC, Schnitzler M, et al. Liver transplantation for hepatocellular carcinoma: expanding special priority to include stage III disease. Arch Surg. 2005;140:459-464; discussion 464. (Pubitemid 40617362)
14. Duffy JP, Vardanian A, Benjamin E, et al. Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA. Ann Surg. 2007;246: 502-509; discussion 509-511. (Pubitemid 47312148)
15. Roayaie S, Frischer JS, Emre SH, et al. Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters. Ann Surg. 2002;235:533-539. (Pubitemid 34258353)
16. Shah SA, Cleary SP, Tan JC, et al. An analysis of resection vs. transplantation for early hepatocellular carcinoma: defining the optimal therapy at a single institution. Ann Surg Oncol. 2007;14: 2608-2614. (Pubitemid 47389575)
17. Decaens T, Roudot-Thoraval F, Hadni-Bresson S, et al. Impact of UCSF criteria according to pre-and post-OLT tumor features: analysis of 479 patients listed for HCC with a short waiting time. Liver Transpl. 2006; 12:1761-1769. (Pubitemid 44911801)
18. Pelletier SJ, Fu S, Thyagarajan V, et al. An intention-to-treat analysis of liver transplantation for hepatocellular carcinoma using organ procurement transplant network data. Liver Transpl. 2009; 15:859-868.
19. Freeman RB Jr. Is waiting time a measure of access to liver transplantation? Is shorter necessarily better. Hepatology. 2007;46:602-603. (Pubitemid 47344798)
20. Liau KH, Ruo L, Shia J, et al. Outcome of partial hepatectomy for large (>10 cm) hepatocellular carcinoma. Cancer. 2005; 104: 1948-1955. (Pubitemid 41513179)
21. Ng KK, Vauthey JN, Pawlik TM, et al. Is hepatic resection for large or multinodular hepatocellular carcinoma justified?. Results from a multi-institutional database. Ann Surg Oncol. 2005;12: 364-373.
22. Llovet JM. Expanding HCC criteria for liver transplant: the urgent need for prospective, robust data. Liver Transpl. 2006;12: 1741-1743. (Pubitemid 44911798)
23. Freeman RB Jr. Model for end-stage liver disease (MELD) for liver allocation: a 5-year score card. Hepatology. 2008;47: 1052-1057. (Pubitemid 351449696)
24. Roayaie S, Llovet JM. Liver transplantation for hepatocellular carcinoma: is expansion of criteria justified?. Clin Liver Dis. 2005; 9:315-328.
25. Schroeder RA, Marroquin CE, Bute BP, et al. Predictive indices of morbidity and mortality after liver resection. Ann Surg. 2006; 243:373-379. (Pubitemid 43327770)
26. Dimick JB, Cowan JA Jr, Knol JA, et al. Hepatic resection in the United States: indications, outcomes, and hospital procedural volumes from a nationally representative database. Arch Surg. 2003;138:185-191. (Pubitemid 36221339)
27. Eppsteiner RW, Csikesz NG, Simons JP, et al. High volume and outcome after liver resection: surgeon or center?. J Gastrointest Surg. 2008;12:1709-1716; discussion 1716.
28. Schwarz RE, Smith DD. Trends in local therapy for hepatocellular carcinoma and survival outcomes in the US population. Am J Surg. 2008;195:829-836. (Pubitemid 351749460)
29. Porrett PM, Peterman H, Rosen M, et al. Lack of benefit of pretransplant locoregional hepatic therapy for hepatocellular cancer in the current MELD era. Liver Transpl. 2006;12:665-673.
30. Heckman JT, Devera MB, Marsh JW, et al. Bridging locoregional therapy for hepatocellular carcinoma prior to liver transplantation. Ann Surg Oncol. 2008;15:3169-3177.